RNA POLYMERASE I TRANSCRIPTION PATHWAY (PW:0000126) Description
The three eukaryotic RNA polymerases (RNAPs)- Pol I, II and III, transcribe different sets of genes and require distinct sets of factors to assemble a specific initiation complex which recruits them on gene promoters. The multi-subunit enzymes are composed of 14 (RNAPI), 12 (RNAPII) and 17 (RNAPIII) sub-units of which some are shared and others are unique, yet converging on an overall similar structural topology. Complexes specific to each of the three systems share the universal transcription factor 'TATA-box binding protein' (TBP) regardless of whether the promoters have a TATA box or not. In addition, modules and domains present in general transcription factors (GTFs) specific for RNAPII are found in subunits of RNAPI and RNAPIII and/or RNAPI and RNAPIII specific factors. The initiation, elongation and termination of transcription are steps shared by all systems, albeit with differing details and/or degrees of complexity. Beyond the shared or related elements, specific factors confer unique topological and functional features to the particular initiation complex associated with the three polymerases and account for the differences in promoter recognition and the class or category of transcribed genes. Pol I transcribes ribosomal RNA, all protein-coding and many non-coding genes are transcribed by pol II, while transfer RNA, the small 5S ribosomal RNA and a subset of small non-coding genes are the realm of pol III mediated transcription. Transcription by RNA pol I is described here.
RNA polymerase I transcription pathway
RNAPI transcription takes place in the nucleolus and its single target is the gene encoding the large ribosomal 47S mammalian precursor (35S in yeast), subsequently processed into the three mature 18S, 28S and 5.8S rRNAs. Co- and post-transcriptional events produce the mature rRNA. An additional rRNA gene, the 5S rRNA is transcribed by RNAPIII, the genes encoding the many ribosomal proteins are the targets of RNAPII transcription. Together they form the ribosomes whose assembly is assisted by a plethora of accessory factors. There are multiple copies of the rRNA gene organized in large clusters at Nucleolar Organizer Regions (NORs). In mammals, there are ~400 copies of rRNA in gene clusters on multiple chromosomes and like in yeast, only a fraction is actively transcribed. Within each cluster the rRNA genes are arranged in a head-to-tail orientation of alternating transcribed and non-transcribed rRNA genes. Pol I promoter is bipartite with a core element (CE) that overlaps with the transcription start site (TSS) and an upstream control element (UCE) that is ~ 100 bp upstream of TSS. The formation of the pre-initiation complex involves binding of Ubtf dimer to UCE and recruitment of SL1 selectivity complex to CE. Human Ubtf contains a series of tandem high mobility group (HMG) boxes that bind and bend DNA. Human SL1 complex contains TBP, four pol I TBP associated factors (TAFs) TAF1A, B, C and D, and TAF12 - a component of pol II complexes TFIID and SAGA. The N-terminus of TAF1B shares homology with TFIIB and the N-terminus of Brf1 component of TFIIIB - the essential GTFs of Pol II and III, respectively. While TBP is a component of SL1 and required for Pol I transcription, it is not clear whether is necessary for basal transcription, suggesting a possible role as a coactivator to facilitate the interaction between Ubtf and SL1. An yeast ortholog, Rrn3 interacts with the TAF1A and B subunits of SL1 and is probably involved in pol I recruitment. Pol I is composed of 14 subunits of which seven are shared with Pol III and of this set, five are shared with Pol II. The FACT complex modulates the chromatin structure to promote transcription The FACT chromatin modulator is composed of SSRP1 and SUPT16H, is thought to act as a histone chaperone and mediate nucleosome reorganization, and it facilitates replication, transcription and DNA repair. FACT associates with and is important for transcription by Pol I and the other two Pol systems; DNA binding is important for its recruitment. Both proteins interact with Pol I subunits while the HMG domain of Ssrp1 probably mediates DNA binding. FACT also interacts with the Paf1 complex involved in elongation. The Paf1 complex (Paf1C) increases the elongation rate of pol I and is also important for Pol II transcription. The complex is composed of five subunits and an additional one is present in human cells. RNAPI has intrinsic RNA hydrolysis and elongation promoting activities. The POLR1E/Paf53/A49 and CD3EAP/Paf49/A34.5 subunits of Pol I have TFIIF-like domains; TFIIF is the Pol II transcription factor whose many roles include enhancement of elongation. The Supt4h1/5h heterodimer (Spt4/5), known for its implication in Pol II transcription elongation, also affects elongation by pol I. Supt5h interacts with both Pol I and II; interactions between the heterodimer and Paf1 complex are reported. Nucleolin - a gene found in all animal, plant and yeast species, regulates the pre-rRNA transcription and processing, and ribosome biogenesis. It binds DNA and like FACT, has chromatin activities. Termination of transcription by Pol I requires the recruitment of factors to specific DNA elements known as terminators - T1-to-T10 or T11 in mouse and human, respectively. Ttf1 binds to terminator elements leading to bending of DNA, that is recognized by Pol I and stops transcription. Release of the primary transcript is catalyzed by Pol I and the release factor Ptrf, originally identified as a Ttf1 interacting partner.
Ribosome biogenesis is energetically very expensive. As such, rRNA synthesis is heavily regulated in response to environmental cues: it is activated in response to nutrients and is repressed in response to stress. Under normal conditions, POLR1E/Paf53/A49 subunit is associated with the histone acetyltransferase Crebbp/Cbp and the NAD+ dependent deacetylase Sirt7. CBP acetylation is reversed by Sirt7; hypocetylation of POLR1E facilitates its association with rDNA and is required for Pol I transcription. On the other hand, Sirt1 deacetylation of TAF1B in response to stress, has an inhibitory effect by impairing binding of SL1 complex to promoters. Stresses activate kinases such as AMPK phosphorylate TAF1A at particular residues and inhibit transcription. Impaired transcription results in lack of nascent pre-rRNA, whose binding by Sirt7 is essential for the nucleolar retention of the enzyme. Consequently, POLR1E stays acetylated leading to reduced rDNA occupancy by Pol I. However, TAF1A phosphorylation at other residues by nutrient and mitogen activated kinases such as mTOR and Erk1/2, is required for Pol I transcription, with mTOR exerting dual effects. Chromatin modification and remodeling play a critical role in delineating the active or silent rRNA promoter states; non-coding RNAs may further contribute to the control of epigenetic regulation. Nucleolar stress activates the p53 signaling to arrest cell cycle or, if necessary, to induce apoptosis. Oncogenes and tumor suppressors influence Pol I transcription. Its connection to cell growth and proliferation makes it a candidate for the development of cancer therapeutics.
To see the ontology report for annotations, GViewer and download, click here ...(less)
Pathway Diagram:
GO TO:
Genes in Pathway:
Symbol
Object Name
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Cavin1
caveolae associated protein 1
ISO
RGD
PMID:23092677
RGD:9588249
NCBI chr10:86,384,401...86,398,240
Ensembl chr10:85,889,036...85,896,120
G
Cdc73
cell division cycle 73
ISO
RGD
PMID:20060942
RGD:9588246
NCBI chr13:57,897,924...58,000,031
Ensembl chr13:55,357,226...55,449,656
G
Crebbp
CREB binding protein
ISO
RGD
PMID:24022641
RGD:9588250
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Ctr9
CTR9 homolog, Paf1/RNA polymerase II complex component
ISO
RGD
PMID:20060942
RGD:9588246
NCBI chr 1:174,571,952...174,601,974
Ensembl chr 1:165,137,215...165,167,303
G
Leo1
LEO1 homolog, Paf1/RNA polymerase II complex component
ISO
RGD
PMID:20060942
RGD:9588246
NCBI chr 8:85,080,036...85,104,471
Ensembl chr 8:76,199,099...76,223,983
G
Ncl
nucleolin
ISO
RGD
PMID:21893173 PMID:25225127
RGD:9588244 , RGD:9588251
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:86,998,019...87,008,136
G
Paf1
PAF1 homolog, Paf1/RNA polymerase II complex component
ISO
RGD
PMID:20060942
RGD:9588246
NCBI chr 1:92,811,197...92,816,775
Ensembl chr 1:83,668,813...83,689,237
G
Polr1a
RNA polymerase I subunit A
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 4:105,508,305...105,572,272
Ensembl chr 4:103,950,051...104,014,020
G
Polr1b
RNA polymerase I subunit B
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 3:136,787,130...136,811,608
Ensembl chr 3:116,333,889...116,358,379
G
Polr1c
RNA polymerase I and III subunit C
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 9:22,233,318...22,237,430
Ensembl chr 9:14,735,714...14,739,852
G
Polr1d
RNA polymerase I and III subunit D
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 RGD:9588262
NCBI chr12:13,084,505...13,118,069
Ensembl chr12:7,970,595...8,005,624
G
Polr1e
RNA polymerase I subunit E
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 5:59,279,456...59,295,346
Ensembl chr 5:59,279,460...59,295,369
G
Polr1f
RNA polymerase I subunit F
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 6:50,053,289...50,070,514
Ensembl chr 6:50,053,289...50,070,514
G
Polr1g
RNA polymerase I subunit G
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 1:88,135,493...88,138,769
Ensembl chr 1:79,007,490...79,010,766
G
Polr1h
RNA polymerase I subunit H
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr20:1,600,170...1,604,088
Ensembl chr20:1,594,936...1,598,854
G
Polr2e
RNA polymerase II, I and III subunit E
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 7:10,317,332...10,321,280
Ensembl chr 7:9,666,716...9,670,643
G
Polr2f
RNA polymerase II, I and III subunit F
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:110,712,572...110,724,234
G
Polr2h
RNA polymerase II, I and III subunit H
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 RGD:9588262
NCBI chr11:93,696,423...93,701,902
Ensembl chr11:80,192,032...80,197,515 Ensembl chr10:80,192,032...80,197,515
G
Polr2k
RNA polymerase II, I and III subunit K
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 , RGD:9588262
NCBI chr 7:69,241,233...69,244,579
Ensembl chr 7:67,356,113...67,357,668
G
Polr2l
RNA polymerase II, I and III subunit L
ISO
RGD
PMID:21893173 PMID:22365827
RGD:9588244 RGD:9588262
NCBI chr 1:205,999,607...206,001,615
Ensembl chr19:8,335,702...8,335,905
G
Rrn3
RRN3 homolog, RNA polymerase I transcription factor
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr10:2,637,016...2,672,338
Ensembl chr10:2,129,978...2,165,663
G
Rtf1
Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)
ISO
RGD
PMID:20060942
RGD:9588246
NCBI chr 3:127,113,171...127,172,761
Ensembl chr 3:106,659,308...106,718,970
G
Sirt1
sirtuin 1
ISO
RGD
PMID:24022641
RGD:9588250
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Sirt7
sirtuin 7
ISO
RGD
PMID:24022641
RGD:9588250
NCBI chr10:106,394,802...106,401,627
Ensembl chr10:105,896,476...105,903,172
G
Skic8
SKI8 subunit of superkiller complex
ISO
RGD
PMID:20060942
RGD:9588246
NCBI chr 8:63,999,669...64,016,959
Ensembl chr 8:55,103,545...55,120,813
G
Ssrp1
structure specific recognition protein 1
ISO
RGD
PMID:21454601
RGD:9588245
NCBI chr 3:90,531,024...90,541,132
Ensembl chr 3:70,118,655...70,134,482
G
Supt16h
SPT16 homolog, facilitates chromatin remodeling subunit
ISO
RGD
PMID:21454601
RGD:9588245
NCBI chr15:27,341,196...27,378,314
Ensembl chr15:24,866,489...24,904,846
G
Supt4h1
SPT4 homolog, DSIF elongation factor subunit
ISO
RGD
PMID:21893173
RGD:9588244
NCBI chr10:73,036,560...73,042,821
Ensembl chr10:72,539,382...72,545,831
G
Supt5h
SPT5 homolog, DSIF elongation factor subunit
ISO
RGD
PMID:21893173
RGD:9588244
NCBI chr 1:92,714,276...92,745,489
Ensembl chr 1:83,586,718...83,616,892
G
Taf12
TATA-box binding protein associated factor 12
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr 5:149,756,826...149,772,886
Ensembl chr 5:144,472,841...144,488,849
G
Taf1a
TATA-box binding protein associated factor, RNA polymerase I subunit A
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr13:97,543,772...97,579,742
Ensembl chr13:95,029,225...95,048,087
G
Taf1b
TATA-box binding protein associated factor, RNA polymerase I subunit B
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr 6:46,845,571...46,923,209
Ensembl chr 6:41,117,420...41,194,593
G
Taf1c
TATA-box binding protein associated factor, RNA polymerase 1 subunit C
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr19:47,652,451...47,658,971
Ensembl chr19:47,652,452...47,658,971
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr 8:12,146,511...12,156,647
Ensembl chr 8:12,146,605...12,156,618
G
Tbp
TATA box binding protein
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr 1:65,136,420...65,153,515
Ensembl chr 1:56,463,618...56,510,016
G
Ttf1
transcription termination factor 1
ISO
RGD
PMID:23092677
RGD:9588249
NCBI chr 3:32,782,544...32,807,202
Ensembl chr 3:12,384,655...12,409,257
G
Ubtf
upstream binding transcription factor
ISO
RGD
PMID:22960599 PMID:21893173
RGD:9588243 , RGD:9588244
NCBI chr10:87,758,346...87,775,377
Ensembl chr10:87,258,217...87,272,969
Pathway Gene Annotations
Disease Annotations Associated with Genes in the RNA polymerase I transcription pathway
Cavin1 congenital generalized lipodystrophy , congenital generalized lipodystrophy type 4 , diabetes mellitus , growth hormone insensitivity syndrome with immune dysregulation 1 , hyper IgE recurrent infection syndrome 1 , methylmalonic acidemia , pulmonary hypertension , Weight Gain Cdc73 breast cancer , Breast Cancer, Familial , colorectal cancer , Familial Cystic Parathyroid Adenomatosis , gastric adenocarcinoma , gastrointestinal stromal tumor , genetic disease , head and neck squamous cell carcinoma , Hereditary Neoplastic Syndromes , hyperparathyroidism , Hyperparathyroidism 1 , Hyperparathyroidism 2 , laryngeal squamous cell carcinoma , lung adenocarcinoma , lung cancer , multiple endocrine neoplasia type 1 , oral squamous cell carcinoma , ossifying fibroma , ovarian cancer , parathyroid adenoma , Parathyroid Cancer , parathyroid carcinoma , Parathyroid Neoplasms , stomach cancer Crebbp acute lymphoblastic leukemia , acute myeloid leukemia , adenoid cystic carcinoma , Agenesis of Corpus Callosum , alcohol use disorder , Alzheimer's disease , amyotrophic lateral sclerosis type 1 , Au-Kline Syndrome , autism spectrum disorder , Developmental Disabilities , diffuse large B-cell lymphoma , epilepsy , esophagus squamous cell carcinoma , follicular lymphoma , genetic disease , glaucoma , head and neck squamous cell carcinoma , hepatocellular carcinoma , Hirschsprung Disease 1 , Hirschsprung's disease , Huntington's disease , Idiopathic Generalized Epilepsy , intellectual disability , Kohlschutter-Tonz syndrome , lung adenocarcinoma , Lung Reperfusion Injury , lung small cell carcinoma , lung squamous cell carcinoma , Marfanoid Mental Retardation Syndrome, Autosomal , Menke-Hennekam Syndrome , Menke-Hennekam Syndrome 1 , multiple myeloma , myelodysplastic syndrome , Myocardial Reperfusion Injury , Nervous System Malformations , NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES , Neurodevelopmental Disorders , pre-eclampsia , Prostatic Neoplasms , Rubinstein-Taybi syndrome , scoliosis , Sezary's disease , short-rib thoracic dysplasia 9 with or without polydactyly , squamous cell carcinoma , teratoma , Thumb Deformity , transitional cell carcinoma , urinary bladder cancer , Uterine Cervical Neoplasms Ctr9 genetic disease , hereditary Wilms' tumor , Hypertelorism , Neurodevelopmental Disorders , Perlman syndrome Leo1 Bloom syndrome , colorectal cancer , paraplegia , spermatogenic failure 57 Ncl Animal Disease Models , autistic disorder , hereditary spastic paraplegia , Joubert syndrome 22 , Left Ventricular Hypertrophy , lung adenocarcinoma , Myocardial Ischemia , Myocardial Reperfusion Injury , Perlman syndrome Paf1 maturity-onset diabetes of the young type 1 , peroxisome biogenesis disorder 1A , type 2 diabetes mellitus Polr1a acrofacial dysostosis Cincinnati type , genetic disease , hereditary spastic paraplegia 31 , Hypomyelinating Leukodystrophy 27 , immunodeficiency 116 , NESCAV syndrome , salt and pepper syndrome Polr1b Mandibulofacial Dysostosis , Treacher Collins syndrome , Treacher Collins syndrome 4 Polr1c CAKUT , combined oxidative phosphorylation deficiency , combined oxidative phosphorylation deficiency 8 , genetic disease , Hearing Loss , hypomyelinating leukodystrophy 11 , hypomyelinating leukodystrophy 26 , infantile Refsum disease , Mandibulofacial Dysostosis , neurodegeneration with brain iron accumulation , progressive leukoencephalopathy with ovarian failure , spondyloepimetaphyseal dysplasia with joint laxity , Treacher Collins syndrome 3 , Zellweger syndrome Polr1d Animal Disease Models , genetic disease , Hearing Loss , lung adenocarcinoma , Mandibulofacial Dysostosis , substance-related disorder , Treacher Collins syndrome , Treacher Collins syndrome 2 Polr1e acromesomelic dysplasia, Maroteaux type , distal arthrogryposis type 1A , frontotemporal dementia and/or amyotrophic lateral sclerosis 6 , galactosemia , primary ciliary dyskinesia Polr1f pleomorphic xanthoastrocytoma Polr1g cerebrooculofacioskeletal syndrome 4 , multiple myeloma Polr1h Experimental Neoplasms , megacolon , Stomach Neoplasms Polr2e cerebral creatine deficiency syndrome , cyclic hematopoiesis , Dwarfism , Peutz-Jeghers syndrome Polr2f adenylosuccinase lyase deficiency , Charcot-Marie-Tooth disease , Deafness , Emery-Dreifuss muscular dystrophy , genetic disease , Hearing Loss , Hirschsprung Disease 1 , Hirschsprung's disease , hypogonadotropic hypogonadism , intellectual disability , Kallmann syndrome , Klinefelter syndrome , myoclonic dystonia 26 , neurodegeneration with brain iron accumulation 2A , PCWH syndrome , Van der Hoeve Halbertsma Waardenburg Gualdi Syndrome , Waardenburg syndrome , Waardenburg syndrome type 1 , Waardenburg syndrome type 2A , Waardenburg syndrome type 2E , Waardenburg syndrome type 4A , Waardenburg syndrome type 4C Polr2h 3-methylcrotonyl-CoA carboxylase 1 deficiency , congenital disorder of glycosylation Id , Currarino syndrome Polr2k Cohen syndrome , Kartagener syndrome , primary ciliary dyskinesia 28 Polr2l Beckwith-Wiedemann syndrome , delta beta-thalassemia , developmental and epileptic encephalopathy , early infantile epileptic encephalopathy , immunodeficiency 39 , neuronal ceroid lipofuscinosis , Segawa Syndrome, Autosomal Recessive Rrn3 autistic disorder , epilepsy , Parkinson's disease , schizophrenia Rtf1 Bloom syndrome , colorectal cancer , dilated cardiomyopathy , mosaic variegated aneuploidy syndrome 1 Sirt1 acute kidney failure , Alzheimer's disease , amyotrophic lateral sclerosis , atherosclerosis , atrial fibrillation , autoimmune disease , autosomal dominant intellectual developmental disorder 70 , Binge Drinking , brain infarction , Brain Injuries , Brain Neoplasms , Breast Neoplasms , Cardiomegaly , Carotid Atherosclerosis , cocaine dependence , colitis , congestive heart failure , demyelinating disease , diabetes mellitus , diabetic retinopathy , endocrine system disease , epilepsy , Experimental Autoimmune Encephalomyelitis , Experimental Autoimmune Myocarditis , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , Fibrosis , Genomic Instability , glucose intolerance , heart disease , Hemorrhagic Shock , human immunodeficiency virus infectious disease , Huntington's disease , Hypertrophy , impotence , Insulin Resistance , Kidney Reperfusion Injury , Left Ventricular Hypertrophy , Liver Injury , Liver Reperfusion Injury , Lung Injury , macular degeneration , metabolic dysfunction-associated steatotic liver disease , Metabolic Syndrome , middle cerebral artery infarction , myocardial infarction , Myocardial Reperfusion Injury , Neoplasm Metastasis , nephrogenic diabetes insipidus , Nerve Degeneration , neurodegenerative disease , neuronal ceroid lipofuscinosis 1 , obesity , osteoporosis , osteosarcoma , Paralysis , Pneumococcal Pneumonia , pneumonia , prostate cancer , Prostatic Neoplasms , retinal disease , senile cataract , steatotic liver disease , systemic scleroderma , thrombosis , type 2 diabetes mellitus , Ventricular Dysfunction, Left , Wallerian Degeneration Sirt7 Reperfusion Injury , steatotic liver disease , systemic scleroderma Skic8 Bloom syndrome , colorectal cancer Ssrp1 intellectual disability Supt16h Brain-Lung-Thyroid Syndrome , cone-rod dystrophy 13 , dextrocardia , genetic disease , neurodevelopmental disorder with dysmorphic facies and thin corpus callosum , Neurodevelopmental Disorders , purine nucleoside phosphorylase deficiency Supt4h1 hereditary breast ovarian cancer syndrome , intellectual disability , Joubert syndrome 1 Supt5h Carpenter syndrome 2 , congenital hypoplastic anemia , craniosynostosis 1 , Diamond-Blackfan anemia , maple syrup urine disease , maturity-onset diabetes of the young type 1 , type 2 diabetes mellitus Taf1a dilated cardiomyopathy , familial restrictive cardiomyopathy 6 , gastrointestinal stromal tumor , Loeys-Dietz syndrome 4 , parathyroid carcinoma , Usher syndrome Taf1b Lynch syndrome , mismatch repair cancer syndrome , orofacial cleft 1 Taf1c autistic disorder , developmental and epileptic encephalopathy 11 , persistent fetal circulation syndrome , primary ciliary dyskinesia , primary ciliary dyskinesia 13 Taf1d Arsenic Poisoning , intellectual disability , skin disease Tbp Alzheimer's disease , amenorrhea , genetic disease , Huntington's disease , late onset Parkinson's disease , schizophrenia , sleep apnea , Spinal Cord Injuries , spinocerebellar ataxia type 17 , Spinocerebellar Ataxias , type 1 diabetes mellitus Ttf1 congenital nongoitrous hypothyroidism 2 , developmental and epileptic encephalopathy , developmental and epileptic encephalopathy 14 , early infantile epileptic encephalopathy , Ehlers-Danlos syndrome classic type 1 , Leigh disease , lung adenocarcinoma , primary coenzyme Q10 deficiency 7 , Rafiq syndrome , tuberous sclerosis 1 Ubtf Cardiomegaly , childhood-onset neurodegeneration with brain atrophy , genetic disease , GRN-related frontotemporal lobar degeneration with TDP43 inclusions , hereditary breast ovarian cancer syndrome , Wilson disease
3-methylcrotonyl-CoA carboxylase 1 deficiency Polr2h acrofacial dysostosis Cincinnati type Polr1a acromesomelic dysplasia, Maroteaux type Polr1e acute kidney failure Sirt1 acute lymphoblastic leukemia Crebbp acute myeloid leukemia Crebbp adenoid cystic carcinoma Crebbp adenylosuccinase lyase deficiency Polr2f Agenesis of Corpus Callosum Crebbp alcohol use disorder Crebbp Alzheimer's disease Crebbp , Sirt1 , Tbp amenorrhea Tbp amyotrophic lateral sclerosis Sirt1 amyotrophic lateral sclerosis type 1 Crebbp Animal Disease Models Ncl , Polr1d Arsenic Poisoning Taf1d atherosclerosis Sirt1 atrial fibrillation Sirt1 Au-Kline Syndrome Crebbp autism spectrum disorder Crebbp autistic disorder Ncl , Rrn3 , Taf1c autoimmune disease Sirt1 autosomal dominant intellectual developmental disorder 70 Sirt1 Beckwith-Wiedemann syndrome Polr2l Binge Drinking Sirt1 Bloom syndrome Leo1 , Rtf1 , Skic8 brain infarction Sirt1 Brain Injuries Sirt1 Brain Neoplasms Sirt1 Brain-Lung-Thyroid Syndrome Supt16h breast cancer Cdc73 Breast Cancer, Familial Cdc73 Breast Neoplasms Sirt1 CAKUT Polr1c Cardiomegaly Sirt1 , Ubtf Carotid Atherosclerosis Sirt1 Carpenter syndrome 2 Supt5h cerebral creatine deficiency syndrome Polr2e cerebrooculofacioskeletal syndrome 4 Polr1g Charcot-Marie-Tooth disease Polr2f childhood-onset neurodegeneration with brain atrophy Ubtf cocaine dependence Sirt1 Cohen syndrome Polr2k colitis Sirt1 colorectal cancer Cdc73 , Leo1 , Rtf1 , Skic8 combined oxidative phosphorylation deficiency Polr1c combined oxidative phosphorylation deficiency 8 Polr1c cone-rod dystrophy 13 Supt16h congenital disorder of glycosylation Id Polr2h congenital generalized lipodystrophy Cavin1 congenital generalized lipodystrophy type 4 Cavin1 congenital hypoplastic anemia Supt5h congenital nongoitrous hypothyroidism 2 Ttf1 congestive heart failure Sirt1 craniosynostosis 1 Supt5h Currarino syndrome Polr2h cyclic hematopoiesis Polr2e Deafness Polr2f delta beta-thalassemia Polr2l demyelinating disease Sirt1 developmental and epileptic encephalopathy Polr2l , Ttf1 developmental and epileptic encephalopathy 11 Taf1c developmental and epileptic encephalopathy 14 Ttf1 Developmental Disabilities Crebbp dextrocardia Supt16h diabetes mellitus Cavin1 , Sirt1 diabetic retinopathy Sirt1 Diamond-Blackfan anemia Supt5h diffuse large B-cell lymphoma Crebbp dilated cardiomyopathy Rtf1 , Taf1a distal arthrogryposis type 1A Polr1e Dwarfism Polr2e early infantile epileptic encephalopathy Polr2l , Ttf1 Ehlers-Danlos syndrome classic type 1 Ttf1 Emery-Dreifuss muscular dystrophy Polr2f endocrine system disease Sirt1 epilepsy Crebbp , Rrn3 , Sirt1 esophagus squamous cell carcinoma Crebbp Experimental Autoimmune Encephalomyelitis Sirt1 Experimental Autoimmune Myocarditis Sirt1 Experimental Diabetes Mellitus Sirt1 Experimental Liver Cirrhosis Sirt1 Experimental Neoplasms Polr1h Familial Cystic Parathyroid Adenomatosis Cdc73 familial restrictive cardiomyopathy 6 Taf1a Fibrosis Sirt1 follicular lymphoma Crebbp frontotemporal dementia and/or amyotrophic lateral sclerosis 6 Polr1e galactosemia Polr1e gastric adenocarcinoma Cdc73 gastrointestinal stromal tumor Cdc73 , Taf1a genetic disease Cdc73 , Crebbp , Ctr9 , Polr1a , Polr1c , Polr1d , Polr2f , Supt16h , Tbp , Ubtf Genomic Instability Sirt1 glaucoma Crebbp glucose intolerance Sirt1 GRN-related frontotemporal lobar degeneration with TDP43 inclusions Ubtf growth hormone insensitivity syndrome with immune dysregulation 1 Cavin1 head and neck squamous cell carcinoma Cdc73 , Crebbp Hearing Loss Polr1c , Polr1d , Polr2f heart disease Sirt1 Hemorrhagic Shock Sirt1 hepatocellular carcinoma Crebbp hereditary breast ovarian cancer syndrome Supt4h1 , Ubtf Hereditary Neoplastic Syndromes Cdc73 hereditary spastic paraplegia Ncl hereditary spastic paraplegia 31 Polr1a hereditary Wilms' tumor Ctr9 Hirschsprung Disease 1 Crebbp , Polr2f Hirschsprung's disease Crebbp , Polr2f human immunodeficiency virus infectious disease Sirt1 Huntington's disease Crebbp , Sirt1 , Tbp hyper IgE recurrent infection syndrome 1 Cavin1 hyperparathyroidism Cdc73 Hyperparathyroidism 1 Cdc73 Hyperparathyroidism 2 Cdc73 Hypertelorism Ctr9 Hypertrophy Sirt1 hypogonadotropic hypogonadism Polr2f hypomyelinating leukodystrophy 11 Polr1c hypomyelinating leukodystrophy 26 Polr1c Hypomyelinating Leukodystrophy 27 Polr1a Idiopathic Generalized Epilepsy Crebbp immunodeficiency 116 Polr1a immunodeficiency 39 Polr2l impotence Sirt1 infantile Refsum disease Polr1c Insulin Resistance Sirt1 intellectual disability Crebbp , Polr2f , Ssrp1 , Supt4h1 , Taf1d Joubert syndrome 1 Supt4h1 Joubert syndrome 22 Ncl Kallmann syndrome Polr2f Kartagener syndrome Polr2k Kidney Reperfusion Injury Sirt1 Klinefelter syndrome Polr2f Kohlschutter-Tonz syndrome Crebbp laryngeal squamous cell carcinoma Cdc73 late onset Parkinson's disease Tbp Left Ventricular Hypertrophy Ncl , Sirt1 Leigh disease Ttf1 Liver Injury Sirt1 Liver Reperfusion Injury Sirt1 Loeys-Dietz syndrome 4 Taf1a lung adenocarcinoma Cdc73 , Crebbp , Ncl , Polr1d , Ttf1 lung cancer Cdc73 Lung Injury Sirt1 Lung Reperfusion Injury Crebbp lung small cell carcinoma Crebbp lung squamous cell carcinoma Crebbp Lynch syndrome Taf1b macular degeneration Sirt1 Mandibulofacial Dysostosis Polr1b , Polr1c , Polr1d maple syrup urine disease Supt5h Marfanoid Mental Retardation Syndrome, Autosomal Crebbp maturity-onset diabetes of the young type 1 Paf1 , Supt5h megacolon Polr1h Menke-Hennekam Syndrome Crebbp Menke-Hennekam Syndrome 1 Crebbp metabolic dysfunction-associated steatotic liver disease Sirt1 Metabolic Syndrome Sirt1 methylmalonic acidemia Cavin1 middle cerebral artery infarction Sirt1 mismatch repair cancer syndrome Taf1b mosaic variegated aneuploidy syndrome 1 Rtf1 multiple endocrine neoplasia type 1 Cdc73 multiple myeloma Crebbp , Polr1g myelodysplastic syndrome Crebbp myocardial infarction Sirt1 Myocardial Ischemia Ncl Myocardial Reperfusion Injury Crebbp , Ncl , Sirt1 myoclonic dystonia 26 Polr2f Neoplasm Metastasis Sirt1 nephrogenic diabetes insipidus Sirt1 Nerve Degeneration Sirt1 Nervous System Malformations Crebbp NESCAV syndrome Polr1a neurodegeneration with brain iron accumulation Polr1c neurodegeneration with brain iron accumulation 2A Polr2f neurodegenerative disease Sirt1 neurodevelopmental disorder with dysmorphic facies and thin corpus callosum Supt16h NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES Crebbp Neurodevelopmental Disorders Crebbp , Ctr9 , Supt16h neuronal ceroid lipofuscinosis Polr2l neuronal ceroid lipofuscinosis 1 Sirt1 obesity Sirt1 oral squamous cell carcinoma Cdc73 orofacial cleft 1 Taf1b ossifying fibroma Cdc73 osteoporosis Sirt1 osteosarcoma Sirt1 ovarian cancer Cdc73 Paralysis Sirt1 paraplegia Leo1 parathyroid adenoma Cdc73 Parathyroid Cancer Cdc73 parathyroid carcinoma Cdc73 , Taf1a Parathyroid Neoplasms Cdc73 Parkinson's disease Rrn3 PCWH syndrome Polr2f Perlman syndrome Ctr9 , Ncl peroxisome biogenesis disorder 1A Paf1 persistent fetal circulation syndrome Taf1c Peutz-Jeghers syndrome Polr2e pleomorphic xanthoastrocytoma Polr1f Pneumococcal Pneumonia Sirt1 pneumonia Sirt1 pre-eclampsia Crebbp primary ciliary dyskinesia Polr1e , Taf1c primary ciliary dyskinesia 13 Taf1c primary ciliary dyskinesia 28 Polr2k primary coenzyme Q10 deficiency 7 Ttf1 progressive leukoencephalopathy with ovarian failure Polr1c prostate cancer Sirt1 Prostatic Neoplasms Crebbp , Sirt1 pulmonary hypertension Cavin1 purine nucleoside phosphorylase deficiency Supt16h Rafiq syndrome Ttf1 Reperfusion Injury Sirt7 retinal disease Sirt1 Rubinstein-Taybi syndrome Crebbp salt and pepper syndrome Polr1a schizophrenia Rrn3 , Tbp scoliosis Crebbp Segawa Syndrome, Autosomal Recessive Polr2l senile cataract Sirt1 Sezary's disease Crebbp short-rib thoracic dysplasia 9 with or without polydactyly Crebbp skin disease Taf1d sleep apnea Tbp spermatogenic failure 57 Leo1 Spinal Cord Injuries Tbp spinocerebellar ataxia type 17 Tbp Spinocerebellar Ataxias Tbp spondyloepimetaphyseal dysplasia with joint laxity Polr1c squamous cell carcinoma Crebbp steatotic liver disease Sirt1 , Sirt7 stomach cancer Cdc73 Stomach Neoplasms Polr1h substance-related disorder Polr1d systemic scleroderma Sirt1 , Sirt7 teratoma Crebbp thrombosis Sirt1 Thumb Deformity Crebbp transitional cell carcinoma Crebbp Treacher Collins syndrome Polr1b , Polr1d Treacher Collins syndrome 2 Polr1d Treacher Collins syndrome 3 Polr1c Treacher Collins syndrome 4 Polr1b tuberous sclerosis 1 Ttf1 type 1 diabetes mellitus Tbp type 2 diabetes mellitus Paf1 , Sirt1 , Supt5h urinary bladder cancer Crebbp Usher syndrome Taf1a Uterine Cervical Neoplasms Crebbp Van der Hoeve Halbertsma Waardenburg Gualdi Syndrome Polr2f Ventricular Dysfunction, Left Sirt1 Waardenburg syndrome Polr2f Waardenburg syndrome type 1 Polr2f Waardenburg syndrome type 2A Polr2f Waardenburg syndrome type 2E Polr2f Waardenburg syndrome type 4A Polr2f Waardenburg syndrome type 4C Polr2f Wallerian Degeneration Sirt1 Weight Gain Cavin1 Wilson disease Ubtf Zellweger syndrome Polr1c
Pathway Annotations Associated with Genes in the RNA polymerase I transcription pathway
Cavin1 RNA polymerase I transcription pathway Cdc73 RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Crebbp aldosterone signaling pathway , androgen signaling pathway , cell cycle pathway, mitotic , cortisol signaling pathway , estrogen signaling pathway , forkhead class A signaling pathway , Hedgehog signaling pathway , histone modification pathway , Huntington's disease pathway , hypoxia inducible factor pathway , influenza A pathway , Jak-Stat signaling pathway , long term potentiation , Notch signaling pathway , nuclear factor, erythroid 2 like 2 signaling pathway , p53 signaling pathway , prostate cancer pathway , renal cell carcinoma pathway , RNA polymerase I transcription pathway , transforming growth factor-beta Smad dependent signaling pathway , transforming growth factor-beta superfamily mediated signaling pathway , tuberculosis pathway , type II interferon signaling pathway , Wnt signaling pathway , Wnt signaling, canonical pathway Ctr9 RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Leo1 RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Ncl RNA polymerase I transcription pathway Paf1 RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Polr1a nucleotide excision repair pathway , purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway Polr1b purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway Polr1c purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway , RNA polymerase III transcription pathway Polr1d RNA polymerase I transcription pathway , RNA polymerase III transcription pathway Polr1e purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway Polr1f RNA polymerase I transcription pathway Polr1g RNA polymerase I transcription pathway Polr1h purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway Polr2e Huntington's disease pathway , purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription pathway , RNA polymerase III transcription pathway Polr2f Huntington's disease pathway , purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription pathway , RNA polymerase III transcription pathway Polr2h Huntington's disease pathway , purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription pathway , RNA polymerase III transcription pathway Polr2k RNA polymerase I transcription pathway , RNA polymerase II transcription pathway , RNA polymerase III transcription pathway Polr2l Huntington's disease pathway , purine metabolic pathway , pyrimidine metabolic pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription pathway , RNA polymerase III transcription pathway Rrn3 mTOR signaling pathway , RNA polymerase I transcription pathway Rtf1 RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Sirt1 histone modification pathway , hypoxia inducible factor pathway , p53 signaling pathway , RNA polymerase I transcription pathway , Sirtuin mediated pathway Sirt7 histone modification pathway , RNA polymerase I transcription pathway , Sirtuin mediated pathway Skic8 RNA degradation pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Ssrp1 cisplatin drug pathway , histone modification pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Supt16h histone modification pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Supt4h1 RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Supt5h RNA polymerase I transcription pathway , RNA polymerase II transcription elongation pathway Taf12 RNA polymerase I transcription pathway , RNA polymerase II transcription initiation pathway Taf1a RNA polymerase I transcription pathway Taf1b RNA polymerase I transcription pathway Taf1c RNA polymerase I transcription pathway Taf1d RNA polymerase I transcription pathway Tbp cisplatin drug pathway , Huntington's disease pathway , RNA polymerase I transcription pathway , RNA polymerase II transcription initiation pathway , RNA polymerase III transcription pathway Ttf1 RNA polymerase I transcription pathway Ubtf cisplatin drug pathway , RNA polymerase I transcription pathway
aldosterone signaling pathway Crebbp androgen signaling pathway Crebbp cell cycle pathway, mitotic Crebbp cisplatin drug pathway Ssrp1 , Tbp , Ubtf cortisol signaling pathway Crebbp estrogen signaling pathway Crebbp forkhead class A signaling pathway Crebbp Hedgehog signaling pathway Crebbp histone modification pathway Crebbp , Sirt1 , Sirt7 , Ssrp1 , Supt16h Huntington's disease pathway Crebbp , Polr2e , Polr2f , Polr2h , Polr2l , Tbp hypoxia inducible factor pathway Crebbp , Sirt1 influenza A pathway Crebbp Jak-Stat signaling pathway Crebbp long term potentiation Crebbp mTOR signaling pathway Rrn3 Notch signaling pathway Crebbp nuclear factor, erythroid 2 like 2 signaling pathway Crebbp nucleotide excision repair pathway Polr1a p53 signaling pathway Crebbp , Sirt1 prostate cancer pathway Crebbp purine metabolic pathway Polr1a , Polr1b , Polr1c , Polr1e , Polr1h , Polr2e , Polr2f , Polr2h , Polr2l pyrimidine metabolic pathway Polr1a , Polr1b , Polr1c , Polr1e , Polr1h , Polr2e , Polr2f , Polr2h , Polr2l renal cell carcinoma pathway Crebbp RNA degradation pathway Skic8 RNA polymerase I transcription pathway Cavin1 , Cdc73 , Crebbp , Ctr9 , Leo1 , Ncl , Paf1 , Polr1a , Polr1b , Polr1c , Polr1d , Polr1e , Polr1f , Polr1g , Polr1h , Polr2e , Polr2f , Polr2h , Polr2k , Polr2l , Rrn3 , Rtf1 , Sirt1 , Sirt7 , Skic8 , Ssrp1 , Supt16h , Supt4h1 , Supt5h , Taf12 , Taf1a , Taf1b , Taf1c , Taf1d , Tbp , Ttf1 , Ubtf RNA polymerase II transcription elongation pathway Cdc73 , Ctr9 , Leo1 , Paf1 , Rtf1 , Skic8 , Ssrp1 , Supt16h , Supt4h1 , Supt5h RNA polymerase II transcription initiation pathway Taf12 , Tbp RNA polymerase II transcription pathway Polr2e , Polr2f , Polr2h , Polr2k , Polr2l RNA polymerase III transcription pathway Polr1c , Polr1d , Polr2e , Polr2f , Polr2h , Polr2k , Polr2l , Tbp Sirtuin mediated pathway Sirt1 , Sirt7 transforming growth factor-beta Smad dependent signaling pathway Crebbp transforming growth factor-beta superfamily mediated signaling pathway Crebbp tuberculosis pathway Crebbp type II interferon signaling pathway Crebbp Wnt signaling pathway Crebbp Wnt signaling, canonical pathway Crebbp
References Associated with the RNA polymerase I transcription pathway:
Knutson BA and Hahn S, Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):265-73. doi: 10.1016/j.bbagrm.2012.08.003. Epub 2012 Aug 30.
Schneider DA Gene. 2012 Feb 10;493(2):176-84. doi: 10.1016/j.gene.2011.08.006. Epub 2011 Aug 26.
Winkler DD and Luger K, J Biol Chem. 2011 May 27;286(21):18369-74. doi: 10.1074/jbc.R110.180778. Epub 2011 Mar 24.
Jaehning JA Biochim Biophys Acta. 2010 May-Jun;1799(5-6):379-88. doi: 10.1016/j.bbagrm.2010.01.001. Epub 2010 Jan 12.
Nemeth A, etal., Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):306-17. doi: 10.1016/j.bbagrm.2012.10.007. Epub 2012 Oct 23.
Grummt I Chromosoma. 2013 Dec;122(6):487-97.
Durut N and Saez-Vasquez J, Gene. 2014 Sep 16. pii: S0378-1119(14)01049-X. doi: 10.1016/j.gene.2014.09.023.
Vannini A and Cramer P, Mol Cell. 2012 Feb 24;45(4):439-46. doi: 10.1016/j.molcel.2012.01.023.
Birch JL, etal., EMBO J. 2009 Apr 8;28(7):854-65. doi: 10.1038/emboj.2009.33. Epub 2009 Feb 12.
Drygin D, etal., Annu Rev Pharmacol Toxicol. 2010;50:131-56. doi: 10.1146/annurev.pharmtox.010909.105844.
Grummt I and Langst G, Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):393-404. doi: 10.1016/j.bbagrm.2012.10.004. Epub 2012 Oct 12.
Hamperl S, etal., Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):405-17. doi: 10.1016/j.bbagrm.2012.12.007. Epub 2013 Jan 3.
Golomb L, etal., FEBS Lett. 2014 Aug 19;588(16):2571-9. doi: 10.1016/j.febslet.2014.04.014. Epub 2014 Apr 18.
Sentenac A and Riva M, Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):251-7. doi: 10.1016/j.bbagrm.2012.10.012. Epub 2012 Nov 7.
Vannini A Biochim Biophys Acta. 2013 Mar-Apr;1829(3-4):258-64. doi: 10.1016/j.bbagrm.2012.09.009. Epub 2012 Sep 29.
Ontology Path Diagram:
Import into Pathway Studio: